EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Assessment of AOPP, TBARS, and Inflammatory Status in Diabetic Nephropathy and Hemodialyzed Patients

Daniel Cosmin Caragea, Lidia Boldeanu iD, Mohamed-Zakaria Assani iD, Mariana-Emilia Caragea, Alexandra-Ștefania Stroe-Ionescu, Romeo Popa, Daniela-Teodora Maria iD, Vlad Pădureanu iD, Cristin Constantin Vere, Mihail Virgil Boldeanu iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms262110670 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Daniel Cosmin Caragea und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Faculty of Medicine, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania. Hauptthemen laut MEDLINE: Diabetic Nephropathies, Renal Dialysis, Thiobarbituric Acid Reactive Substances, Inflammation. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Medicine and Pharmacy of Craiova, Romania.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We compared oxidative markers and their links to inflammation in diabetic nephropathy and hemodialysis to identify independent determinants. We studied 180 adults, 90 patients with type 2 diabetes and diabetic nephropathy and 90 patients on hemodialysis. We measured serum advanced oxidation protein products (AOPP) and thiobarbituric acid reactive substances (TBARS) by enzyme-linked immunosorbent assay (ELISA). Partial correlations were adjusted for age, sex, and albumin with false discovery rate (FDR) control. Principal component analysis (PCA) summarized inflammatory indices and linear models tested predictors of AOPP and TBARS. Oxidative damage was higher in hemodialysis, with AOPP median 25.80 versus 5.06 and TBARS 8.49 versus 1.89, p less than 0.0001. C reactive protein (CRP) and mean corpuscular volume-to-lymphocyte ratio (MCVL) were higher in patients ongoing hemodialysis; systemic immune-inflammation index (SII) was higher in diabetic nephropathy. PCA yielded a dominant inflammation axis in both cohorts, 74.73 percent in hemodialysis and 85.20 percent in diabetic nephropathy. In regression, creatinine (β = 2.47, p = 0.026) predicted AOPP in hemodialysis. Dialysis vintage inversely predicted TBARS, β = −0.2305, p = 0.0209. In diabetic nephropathy, the PCA inflammation score predicted AOPP, β = 1.134, p = 0.0003. Protein oxidation tracked systemic inflammation in diabetic nephropathy, but not in hemodialysis. AOPP outperformed TBARS as an inflammatory partner and a practical monitoring candidate in diabetic kidney disease. Prospective studies should test for prognostic value and therapy sensitivity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetic NephropathiesRenal DialysisThiobarbituric Acid Reactive SubstancesInflammationAdvanced Oxidation Protein ProductsHumansMaleFemaleMiddle AgedAgedBiomarkersDiabetes Mellitus, Type 2Oxidative StressAdultC-Reactive Protein

Stichwörter der Autor:innen

AOPPTBARSchronic kidney diseasediabetic nephropathyhemodialysisinflammationoxidative stress

Substanzen

Thiobarbituric Acid Reactive SubstancesAdvanced Oxidation Protein ProductsBiomarkersC-Reactive Protein

Autor:innen und Institutionen

  • Department of Nephrology, Faculty of Medicine, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.
  • Department of Microbiology, Faculty of Medicine, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.
  • Doctoral School, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.
  • Department of Immunology, Faculty of Medicine, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.
  • Department of Pharmacology, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.
  • Department of Internal Medicine, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.

ORCID-Profile: Lidia Boldeanu, Mohamed-Zakaria Assani, Daniela-Teodora Maria, Vlad Pădureanu, Mihail Virgil Boldeanu

Förderung

  • University of Medicine and Pharmacy of Craiova, Romania

Zitieren

APA

Caragea, D. C., Boldeanu, L., Assani, M. Z., Caragea, M. E., Stroe-Ionescu, A. Ș., Popa, R., Maria, D. T., Pădureanu, V., Vere, C. C., & Boldeanu, M. V. (2025). Assessment of AOPP, TBARS, and Inflammatory Status in Diabetic Nephropathy and Hemodialyzed Patients. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms262110670

Vancouver

Caragea DC, Boldeanu L, Assani MZ, Caragea ME, Stroe-Ionescu AȘ, Popa R, et al. Assessment of AOPP, TBARS, and Inflammatory Status in Diabetic Nephropathy and Hemodialyzed Patients. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms262110670

BibTeX
@article{Caragea2025,
  author = {Caragea, Daniel Cosmin and Boldeanu, Lidia and Assani, Mohamed-Zakaria and Caragea, Mariana-Emilia and Stroe-Ionescu, Alexandra-Ștefania and Popa, Romeo and Maria, Daniela-Teodora and Pădureanu, Vlad and Vere, Cristin Constantin and Boldeanu, Mihail Virgil},
  title = {Assessment of AOPP, TBARS, and Inflammatory Status in Diabetic Nephropathy and Hemodialyzed Patients},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms262110670}
}
Kostenlos starten →